Location History:
- Falls Chruch, VA (US) (2000)
- Falls Church, VA (US) (2000 - 2004)
- Arlington, VA (US) (1997 - 2005)
Company Filing History:
Years Active: 1997-2005
Title: Sheri J Olson: Innovator in Genetic Research
Introduction
Sheri J Olson is a prominent inventor based in Arlington, VA (US). She has made significant contributions to the field of genetics, particularly in relation to the BRCA1 gene, which is crucial for understanding breast and ovarian cancer susceptibility. With a total of 7 patents, her work has paved the way for advancements in genetic testing and therapy.
Latest Patents
One of Olson's latest patents focuses on the coding sequences of the human BRCA1 gene. This invention includes isolated coding sequences and the corresponding protein sequences they code for. Specifically, it provides three coding sequences of the BRCA1 gene along with their frequencies of occurrence. Additionally, the patent outlines a method for determining the consensus sequence for any gene. Another significant aspect of this invention is a method for identifying individuals with an increased genetic susceptibility to breast or ovarian cancer due to inherited mutations in their BRCA1 gene. Furthermore, her invention relates to methods of performing gene therapy using the isolated BRCA1 coding sequences.
Another patent addresses the coding sequence haplotype of the human BRCA1 gene. This invention also includes isolated coding sequences and the protein sequences they code for. The BRCA1(omi4) gene sequence is provided, which is instrumental in identifying individuals with a heightened risk of breast or ovarian cancer due to inherited mutations. This patent also encompasses methods for gene therapy and protein replacement therapy using the BRCA1(omi4) protein.
Career Highlights
Throughout her career, Sheri J Olson has worked with notable companies such as Oncormed, Inc. and Gene Logic, Inc. Her expertise in genetic research has been instrumental in advancing the understanding of cancer genetics and developing innovative therapeutic approaches.
Collaborations
Some of her notable coworkers include Patricia D Murphy and Bin Zeng, who have collaborated with her on various projects in the field of genetics.
Conclusion
Sheri J Olson's contributions to genetic research, particularly regarding the BRCA1 gene, have had a profound impact on the understanding and treatment of breast and ovarian cancer. Her innovative patents and collaborations continue to influence the field and offer hope for improved genetic therapies.